North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

North America digital respiratory solutions market is expected to grow by 34.4% annually in the forecast period and reach $155.05 million by 2030 driven by the rising demand for respiratory aids and air purification amid COVID-19 pandemic.

Highlighted with 24 tables and 39 figures, this 98-page report “North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Five Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Therapeutic Devices

Inhalers
Nebulizers

Diagnostic Devices

Spirometers
Asthma Monitors
Other Diagnostic Devices

Sensors and Apps

Based on Indication, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
COVID-19 Caused Diseases
Other Diseases

Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Geographically, the following national/local markets are fully investigated:

U.S.
Canada
Mexico

For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America digital respiratory solutions market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AsthmaMD
AstraZeneca plc
Boehringer Ingelheim International GmbH
Capsule Technologies, Inc.
Cohero Health
GlaxoSmithKline plc
Kaia Health Software GmbH
Medical International Research (MIR)
Novartis AG
NuvoAir
Reciprocal Labs (Propeller Health)
Sensiron AG
Tactio Health
Teva Pharmaceuticals Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction

1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of North America Market by Product Type

3.1 Market Overview by Product Type
3.2 Therapeutic Devices
3.2.1 Inhalers
3.2.2 Nebulizers
3.3 Diagnostic Devices
3.3.1 Spirometers
3.3.2 Asthma Monitors
3.3.3 Other Diagnostic Devices
3.4 Sensors and Apps

4 Segmentation of North America Market by Indication

4.1 Market Overview by Indication
4.2 Asthma
4.3 Chronic Obstructive Pulmonary Disease (COPD)
4.4 COVID-19 Caused Diseases
4.5 Other Diseases

5 Segmentation of North America Market by Distribution Channel

5.1 Market Overview by Distribution Channel
5.2 Hospital Pharmacies
5.3 Retail Pharmacies
5.4 Online Pharmacies

6 North America Market 2019-2030 by Country

6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico

7 Competitive Landscape

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles

3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AsthmaMD
AstraZeneca plc
Boehringer Ingelheim International GmbH
Capsule Technologies, Inc.
Cohero Health
GlaxoSmithKline plc
Kaia Health Software GmbH
Medical International Research (MIR)
Novartis AG
NuvoAir
Reciprocal Labs (Propeller Health)
Sensiron AG
Tactio Health
Teva Pharmaceuticals Industries Ltd.

8 Investing in North America Market: Risk Assessment and Management

8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)

List of Tables

Table 1. Snapshot of North America Digital Respiratory Solutions Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in North America Digital Respiratory Solutions Market
Table 3. North America Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 4. North America Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn
Table 5. North America Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn
Table 6. North America Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 7. North America Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 8. North America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn
Table 9. U.S. Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 10. U.S. Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 11. U.S. Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 12. Canada Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 13. Canada Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 14. Canada Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 15. Mexico Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 16. Mexico Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 17. Mexico Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 18. 3M Health Care Limited: Company Snapshot
Table 19. 3M Health Care Limited: Business Segmentation
Table 20. 3M Health Care Limited: Product Portfolio
Table 21. 3M Health Care Limited: Revenue, 2016-2018, $ mn
Table 22. 3M Health Care Limited: Recent Developments
Table 23. Risk Evaluation for Investing in North America Market, 2019-2030
Table 24. Critical Success Factors and Key Takeaways

List of Figures

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. North America Digital Respiratory Solutions Market, 2019-2030, $ mn
Figure 6. Primary Drivers and Impact Factors of North America Digital Respiratory Solutions Market
Figure 7. GDP per capita in the World, 1960-2018, $ thousand
Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 9. Worldwide Connected Devices by Device Type, 2014-2022, billion units
Figure 10. Primary Restraints and Impact Factors of North America Digital Respiratory Solutions Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of North America Digital Respiratory Solutions Market
Figure 13. Breakdown of North America Digital Respiratory Solutions Market by Product Type, 2019-2030, % of Sales Revenue
Figure 14. North America Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%)
Figure 15. North America Digital Respiratory Solutions Market: Therapeutic Devices, 2019-2030, $ mn
Figure 16. North America Digital Respiratory Solutions Market: Inhalers, 2019-2030, $ mn
Figure 17. North America Digital Respiratory Solutions Market: Nebulizers, 2019-2030, $ mn
Figure 18. North America Digital Respiratory Solutions Market: Diagnostic Devices, 2019-2030, $ mn
Figure 19. North America Digital Respiratory Solutions Market: Spirometers, 2019-2030, $ mn
Figure 20. North America Digital Respiratory Solutions Market: Asthma Monitors, 2019-2030, $ mn
Figure 21. North America Digital Respiratory Solutions Market: Other Diagnostic Devices, 2019-2030, $ mn
Figure 22. North America Digital Respiratory Solutions Market: Sensors and Apps, 2019-2030, $ mn
Figure 23. Breakdown of North America Digital Respiratory Solutions Market by Indication, 2019-2030, % of Sales Revenue
Figure 24. North America Addressable Market Cap in 2020-2030 by Indication, Value ($ mn) and Share (%)
Figure 25. North America Digital Respiratory Solutions Market: Asthma, 2019-2030, $ mn
Figure 26. North America Digital Respiratory Solutions Market: Chronic Obstructive Pulmonary Disease (COPD), 2019-2030, $ mn
Figure 27. North America Digital Respiratory Solutions Market: COVID-19 Caused Diseases, 2019-2030, $ mn
Figure 28. North America Digital Respiratory Solutions Market: Other Diseases, 2019-2030, $ mn
Figure 29. Breakdown of North America Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, % of Revenue
Figure 30. North America Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%)
Figure 31. North America Digital Respiratory Solutions Market: Hospital Pharmacies, 2019-2030, $ mn
Figure 32. North America Digital Respiratory Solutions Market: Retail Pharmacies, 2019-2030, $ mn
Figure 33. North America Digital Respiratory Solutions Market: Online Pharmacies, 2019-2030, $ mn
Figure 34. Breakdown of North America Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. U.S. Digital Respiratory Solutions Market, 2019-2030, $ mn
Figure 37. Canada Digital Respiratory Solutions Market, 2019-2030, $ mn
Figure 38. Digital Respiratory Solutions Market in Mexico, 2015-2030, $ mn
Figure 39. Growth Stage of North America Digital Respiratory Solutions Industry over the Forecast Period